138 related articles for article (PubMed ID: 34962752)
1. Mimic Lipoproteins Responsive to Intratumoral pH and Allosteric Enzyme for Efficient Tumor Therapy.
Li J; Wang H; Xu J; Wu S; Han M; Li J; Wang Q; Ge Z
ACS Appl Mater Interfaces; 2022 Jan; 14(1):404-416. PubMed ID: 34962752
[TBL] [Abstract][Full Text] [Related]
2. Tumor targeting effects of a novel modified paclitaxel-loaded discoidal mimic high density lipoproteins.
Wang J; Jia J; Liu J; He H; Zhang W; Li Z
Drug Deliv; 2013 Nov; 20(8):356-63. PubMed ID: 24079327
[TBL] [Abstract][Full Text] [Related]
3. Arachidonic acid-modified lovastatin discoidal reconstituted high density lipoprotein markedly decreases the drug leakage during the remodeling behaviors induced by lecithin cholesterol acyltransferase.
He H; Liu L; Bai H; Wang J; Zhang Y; Zhang W; Zhang M; Wu Z; Liu J
Pharm Res; 2014 Jul; 31(7):1689-709. PubMed ID: 24449440
[TBL] [Abstract][Full Text] [Related]
4. Sterically stabilized recombined HDL composed of modified apolipoprotein A-I for efficient targeting toward glioma cells.
Li J; Han M; Li J; Ge Z; Wang Q; Zhou K; Yin X
Drug Deliv; 2020 Dec; 27(1):530-541. PubMed ID: 32241173
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-mimicking nanotherapeutics reconstituted with chenodeoxycholic acid modified protein for efficient tumor targeting.
Hu Y; Zou J; Wang Q; Chen Y; Wang H; Li J
Eur J Pharm Biopharm; 2024 Mar; 196():114184. PubMed ID: 38244896
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Remodeling Behaviors with Arachidonic Acid Modification for Enhanced in vivo Antiatherogenic Efficacies of Lovastatin-loaded Discoidal Recombinant High Density Lipoprotein.
He H; Zhang M; Liu L; Zhang S; Liu J; Zhang W
Pharm Res; 2015 Oct; 32(10):3415-31. PubMed ID: 26040661
[TBL] [Abstract][Full Text] [Related]
7. Long-chain polyunsaturated fatty acids in the sn-2 position of phosphatidylcholine decrease the stability of recombinant high density lipoprotein apolipoprotein A-I and the activation energy of the lecithin:cholesterol acyltransferase reaction.
Parks JS; Gebre AK
J Lipid Res; 1997 Feb; 38(2):266-75. PubMed ID: 9162746
[TBL] [Abstract][Full Text] [Related]
8. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterizations, and in vitro metabolic processes of paclitaxel-loaded discoidal recombinant high-density lipoproteins.
Jia J; Xiao Y; Liu J; Zhang W; He H; Chen L; Zhang M
J Pharm Sci; 2012 Aug; 101(8):2900-8. PubMed ID: 22628199
[TBL] [Abstract][Full Text] [Related]
10. Binding of lecithin:cholesterol acyltransferase to reconstituted high density lipoproteins is affected by their lipid but not apolipoprotein composition.
Bolin DJ; Jonas A
J Biol Chem; 1994 Mar; 269(10):7429-34. PubMed ID: 8125962
[TBL] [Abstract][Full Text] [Related]
11. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements.
Cho KH; Durbin DM; Jonas A
J Lipid Res; 2001 Mar; 42(3):379-89. PubMed ID: 11254750
[TBL] [Abstract][Full Text] [Related]
12. Lipid-free apolipoproteins A-I and A-II promote remodeling of reconstituted high density lipoproteins and alter their reactivity with lecithin:cholesterol acyltransferase.
Durbin DM; Jonas A
J Lipid Res; 1999 Dec; 40(12):2293-302. PubMed ID: 10588955
[TBL] [Abstract][Full Text] [Related]
13. Remodelling of reconstituted high density lipoproteins by lecithin: cholesterol acyltransferase.
Liang HQ; Rye KA; Barter PJ
J Lipid Res; 1996 Sep; 37(9):1962-70. PubMed ID: 8895062
[TBL] [Abstract][Full Text] [Related]
14. Dietary fatty acid modification of HDL phospholipid molecular species alters lecithin: cholesterol acyltransferase reactivity in cynomolgus monkeys.
Thornburg JT; Parks JS; Rudel LL
J Lipid Res; 1995 Feb; 36(2):277-89. PubMed ID: 7751815
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and atherosclerotic lesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins.
Zhang W; He H; Liu J; Wang J; Zhang S; Zhang S; Wu Z
Biomaterials; 2013 Jan; 34(1):306-19. PubMed ID: 23069716
[TBL] [Abstract][Full Text] [Related]
16. Reconstituted high density lipoprotein (rHDL), a versatile drug delivery nanoplatform for tumor targeted therapy.
Mei Y; Tang L; Xiao Q; Zhang Z; Zhang Z; Zang J; Zhou J; Wang Y; Wang W; Ren M
J Mater Chem B; 2021 Jan; 9(3):612-633. PubMed ID: 33306079
[TBL] [Abstract][Full Text] [Related]
17. Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding.
Bolin DJ; Jonas A
J Biol Chem; 1996 Aug; 271(32):19152-8. PubMed ID: 8702592
[TBL] [Abstract][Full Text] [Related]
18. Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase.
Clay MA; Pyle DH; Rye KA; Barter PJ
J Biol Chem; 2000 Mar; 275(12):9019-25. PubMed ID: 10722751
[TBL] [Abstract][Full Text] [Related]
19. Dual-functional bio-derived nanoparticulates for apoptotic antitumor therapy.
Ding Y; Wang Y; Opoku-Damoah Y; Wang C; Shen L; Yin L; Zhou J
Biomaterials; 2015 Dec; 72():90-103. PubMed ID: 26344366
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants.
Jonas A; von Eckardstein A; Kézdy KE; Steinmetz A; Assmann G
J Lipid Res; 1991 Jan; 32(1):97-106. PubMed ID: 1901346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
